Red Ginseng Extract for Blood Sugar Control in Prediabetic Adults
Author Information
Author(s): Jeong Yoonseon, Lee Seung Ho, Shim Sung Lye, Jang Kyoung Hwa, Kim Jong Han
Primary Institution: Korea Ginseng Corporation Research Institute
Hypothesis
This study aims to assess the efficacy and safety of Red Ginseng Extract Powder (RGEP) in achieving glycemic control in prediabetic Korean adults.
Conclusion
RGEP might be effective in achieving glycemic control in prediabetic Korean adults.
Supporting Evidence
- There were significant differences in fasting blood glucose and other glycemic control parameters between the RGEP and placebo groups.
- RGEP showed a significant time-dependent decrease in dipeptidyl peptidase-4 levels.
- There were no treatment-emergent adverse events reported in either treatment arm.
Takeaway
This study tested a ginseng supplement to see if it helps people who are at risk of diabetes control their blood sugar better.
Methodology
A 12-week, single-center, randomized, double-blind, parallel-group, placebo-controlled study with 98 participants divided into RGEP and placebo groups.
Potential Biases
Selection bias could not be completely ruled out due to the single-center design.
Limitations
The study is small-scale and single-center, which may limit the generalizability of the results.
Participant Demographics
Korean adults aged 19 and older with prediabetes.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website